Riquet Marc, Pricopi Ciprian, Legras Antoine, Arame Alex, Badia Alain, Le Pimpec Barthes Françoise
General Thoracic Surgery Department, Georges Pompidou European Hospital, Paris, France.
J Thorac Dis. 2017 Mar;9(3):E327-E332. doi: 10.21037/jtd.2017.03.46.
The greater the number of lymph node (LN) sampled (NLNsS) during lung cancer surgery, the lower the risk of underestimating the pN-status and the better the outcome of the pN0-patients due to stage-migration. Thus, regarding LN sampling "to be or not to be", number is the question. Recent studies advocate removing 10 LNs. The most suitable NLNsS is unfortunately impossible to establish by mathematics. A too high NLNsS variability exists, based on anatomy, surgery and pathology. The methodology may vary according to Inter-institutional differences in the surgical approach regarding LN inspection and number sampling. The NLNsS increases with the type of resection: sublobar, lobectomy or pneumonectomy. Concerning pathology, one LN may be divided into several pieces, leading to number overestimation. The pathological examination is limited by the number of slices analyzed by LN. The examined LNs can arbitrarily depend on the probability of detecting nodal metastasis. In fact, the only way to ensure the best NLNsS and the best pN-staging is to remove all LNs from the ipsilateral mediastinal and hilar LN-stations as they are discovered by thoroughly dissecting their anatomical locations. In doing so, a deliberate lack of harvest of LNs is unlikely, number turns out not to be the question anymore and a low NLNsS no longer means incomplete surgery. This prevents from judging as incomplete a complete LN dissection in a patient with a small NLNsS and from considering as complete a true incomplete one in a patient with a great NLNsS. Precise information describing the course of the operation and furnished in the surgeon's reports is also advisable to further improve the quality of LN-dissection, which ultimately might be beneficial in the long-term to patients. However, that procedure is of limited interest in pN-staging if LNs are not thoroughly examined and also described by the pathologist.
肺癌手术中采样的淋巴结数量(NLNsS)越多,低估pN分期的风险越低,并且由于分期迁移,pN0患者的预后越好。因此,对于淋巴结采样“做或不做”,数量是关键问题。最近的研究主张切除10个淋巴结。不幸的是,最合适的NLNsS无法通过数学方法确定。基于解剖学、手术和病理学,NLNsS存在过高的变异性。根据机构间在淋巴结检查和数量采样的手术方法上的差异,方法可能会有所不同。NLNsS随着切除类型的不同而增加:亚肺叶切除、肺叶切除或全肺切除。在病理学方面,一个淋巴结可能被切成几块,导致数量高估。病理检查受每个淋巴结分析切片数量的限制。所检查的淋巴结可能随意地取决于检测到淋巴结转移的概率。事实上,确保最佳NLNsS和最佳pN分期的唯一方法是在发现同侧纵隔和肺门淋巴结站的所有淋巴结时,通过彻底解剖其解剖位置将其全部切除。这样做,不太可能故意不采集淋巴结,数量不再是问题,低NLNsS也不再意味着手术不完整。这可以防止将NLNsS小的患者的完整淋巴结清扫判定为不完整,也可以防止将NLNsS大的患者的真正不完整清扫判定为完整。外科医生报告中提供的描述手术过程的精确信息也有助于进一步提高淋巴结清扫的质量,这最终可能对患者长期有益。然而,如果病理学家没有对淋巴结进行彻底检查和描述,那么该程序在pN分期方面的意义有限。